Chemo101.com officially launched during ASH meeting

Chemo101.com, a new educational website for cancer patients, made its official launch during the American Society of Hematology meeting this past weekend in Orlando, FL. The brainchild of veteran healthcare consultant to the pharmaceutical industry, Kristin Gustafson, Chemo101 is an innovative and comprehensive new platform that provides those undergoing chemotherapy treatment with the most up-to-date resources and information they need, all in one easy to access place online. From chemo treatment options and side effects, to insurance matters and other associated costs, Chemo101 offers patients and caregivers a one-stop resource to help navigate through a confusing and unfamiliar process.  It provides information to ease the anxiety and fears that come with diagnosis and treatment.

Says Gustafson, President and founder of Chemo101, "Now cancer patients and caregivers will have their own comprehensive site to get the latest information on all matters related to the chemotherapy experience.  For years we've been listening closely to healthcare providers and patients share their personal challenges in managing the physical and financial impact of cancer treatments. Many patients have to stop or alter therapy due to unforeseen side effects or escalating treatment costs.  We've made it our goal to help patients access critical information about their treatments and financial options in a simple and concise way that will allow them to take more control in the decision making process.  What makes Chemo101 unique to other resources is that we have incorporated learning principles that will help individuals with varying backgrounds better understand the information. It's an information source that's reliable, user-friendly and of true value."

SOURCE Chemo101.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revolutionary strategy offers hope for type 1 diabetes treatment